About Jubilant Radiopharma
Jubilant Radiopharma, a business segment of Jubilant Pharmova Limited, is an industry-leading radiopharmaceutical business that comprises development, manufacturing and commercialization of products through its Radiopharmaceuticals business and distribution through the Radiopharmacies division. Jubilant Radiopharma’s manufactured products are used in the diagnosis, treatment and monitoring of various diseases with specialization in lung, thyroid, bone and cardiac imaging products as well as in thyroid disease therapy. The division’s Radiopharmacies business is the second largest radiopharmacy network in the U.S. with 43 radiopharmacies and 3 PET manufacturing facilities, distributing nuclear medicine products to members of the largest national Group Purchasing Organizations (GPOs), regional health systems, stand-alone imaging centers, cardiologists and hospitals. This business has over 30 years of experience in serving the US nuclear medicine community and its current geographical reach enables it to serve over four million patients yearly. The Radiopharmacies business complements the Company’s Radiopharmaceuticals business and provides it with direct access to hospital networks. Jubilant Radiopharma is focused on “Improving Lives Through Nuclear Medicine”.
Back to HCB News
